68Ga-DOTA-tyr3-Octreotide PET
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 68Ga-DOTA-tyr3-Octreotide PET, covering 2021-02-02 to 2021-02-02. Get the full timeline:
Most recent: Clinical Trial Update: Safety of 68Ga-DOTA-tyr3-Octreotide PET in Diagnosis of Solid Tumors [Phase 1, Phase 2]